Drug Discovery Current Events | Drug Discovery News | 3
|
| Page
3 of
43 |
851 Results |
|
|
|
Sort By:
Page Views | Date |
Research offers hope for alcoholics
Scientists at Melbourne's Howard Florey Institute have discovered a system in the brain that stops an alcoholic's craving for alcohol, as well as prevent relapse once they have recovered from alcohol addiction. view more (2006-12-13)
Research offers hope for alcoholics
Scientists at Melbourne's Howard Florey Institute have discovered a system in the brain that stops an alcoholic's craving for alcohol, as well as prevent relapse once they have recovered from alcohol addiction. view more (2006-12-13)
Drug treatment likely to be based on biased evidence
Drug treatment is likely to be founded on biased evidence because drug companies tend to publish studies with more favourable results, suggest researchers in this week’s BMJ. view more (2003-05-28)
New compound stops brain cell degeneration in Alzheimer's disease
Drug discovery researchers at Northwestern University have developed a novel orally administered compound specifically targeted to suppress brain cell inflammation and neuron loss associated with Alzheimer's disease. view more (2006-01-20)
DISTINGUISHED SERVICE AWARD BESTOWED - Pharmaceutical leader applauded for dedicated service to international Society
16 May 2003, London, UK: Dr Barry Porter, Chief Operating Officer, Curidium Ltd, will be awarded with the prestigious Society of Chemical Industry (SCI) Distinguished Service Award today at SCI International Headquarters in Belgrave Square, London, UK. The award will be given in recognition of Dr Porter's extensive service to the Society. He has... view more... (2003-05-16)
Discovery in worms by Queen's researchers points to more targeted cancer treatment
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. view more (2009-11-11)
Marijuana-like brain chemicals work as antidepressant
American and Italian researchers have found that boosting the amounts of a marijuana-like brain transmitter called anandamide produces antidepressant effects in test rats. view more (2007-11-06)
Research Shows Prescribers Miss Possibly Dangerous Drug Interactions
Research led by The University of Arizona College of Pharmacy has found that medication prescribers correctly identified fewer than half of drug pairs with potentially dangerous drug-drug interactions. view more (2009-07-14)
Research identifies protein in mice that regulates bone formation
Osteoporosis, a disease characterized by a decrease in bone mass and density and which makes people more susceptible to bone fractures and deformities, afflicts some 10 million Americans over the age of 50. view more (2006-06-23)
Researchers discover protein that controls bone growth
A research team led by Dr. Pierre Moffatt of the Shriners Hospital for Children in Montreal and McGill University's Department of Human Genetics has uncovered the molecular mechanism by which the protein osteocrin controls bone growth - a discovery that may have important implications for people suffering from bone diseases affecting skeletal... view more... (2007-12-20)
Herpes drug inhibits HIV in patients infected with both viruses
Researchers at the U.S. National Institutes of Health (NIH), McGill University and other institutions have discovered how a simple antiviral drug developed decades ago suppresses HIV in patients who are also infected with herpes. view more (2008-09-16)
New European Drugs Research Project
The University of Kent at Canterbury (UKC) is launching a major European drugs research project at the Drugs and Society Conference at Ashford International Hotel, Kent on 24th October. The £500,000 EU-funded project will investigate the use of court-ordered drug treatment in the UK, the Netherlands, Germany, Italy, Austria and Switzerland.... view more... (2002-10-11)
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Patient with rare disorder responds to cancer drug
A rare disorder caused by an excess of two types of immune cells-the mast cell found in various tissues and its blood-based twin, the basophil-has successfully been treated with a cancer drug, report scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). view more (2008-02-14)
U of M study finds new insight on therapy for a devastating parasitic disease
University of Minnesota Medical School researchers have discovered an important new insight into how a commonly prescribed drug may work to treat those infected by a parasitic flatworm. view more (2009-06-24)
Drug discovery process more accurate, less expensive using novel mass spectrometry application
Cancer and cell biology experts at the University of Cincinnati (UC) have developed a new mass spectrometry-based tool they say provides more precise, cost-effective data collection for drug discovery efforts. view more (2009-09-18)
Future therapies for stroke may block cell death
A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University. view more (2007-06-14)
Concern that research sponsored by drug companies is biased
Research funded by drug companies is more likely to produce results that favour the sponsor’s product than research funded by other sources, claim researchers in this week’s BMJ. view more (2003-05-28)
NYU researchers demonstrate activity of mebendazole in metastatic melanoma
Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma. view more (2008-08-07)
A scientific breakthrough on the control of the bad cholesterol
A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor view more (2008-11-25)
|
|
| Page
3 of
43 |
851 Results |
|
|
|
Sort By:
Page Views | Date |
|
